These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 7074649)

  • 21. Involved-field radiotherapy is equally effective and less toxic compared with extended-field radiotherapy after four cycles of chemotherapy in patients with early-stage unfavorable Hodgkin's lymphoma: results of the HD8 trial of the German Hodgkin's Lymphoma Study Group.
    Engert A; Schiller P; Josting A; Herrmann R; Koch P; Sieber M; Boissevain F; De Wit M; Mezger J; Duhmke E; Willich N; Muller RP; Schmidt BF; Renner H; Muller-Hermelink HK; Pfistner B; Wolf J; Hasenclever D; Loffler M; Diehl V;
    J Clin Oncol; 2003 Oct; 21(19):3601-8. PubMed ID: 12913100
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Combination chemotherapy and survival in advanced Hodgkin's disease.
    Canellos GP; Young RC; Berard CW; DeVita VT
    Arch Intern Med; 1973 Mar; 131(3):388-90. PubMed ID: 4569375
    [No Abstract]   [Full Text] [Related]  

  • 23. [Chemotherapy-selective nodal irradiation in Hodgkin's disease clinical stages IA-IIIB. Results of a prospective clinical trial including 334 patients (author's transl)].
    Andrieu JM; Asselain B; Bayle C; Teillet F; Clot P; Dana M; Katz M; Brière J; Jacquillat C; Bernard J
    Bull Cancer; 1981; 68(2):190-9. PubMed ID: 7016225
    [No Abstract]   [Full Text] [Related]  

  • 24. [Combined cyclic treatment of generalized Hodgkin's disease by the MOPP program. Preliminary results and observed complications].
    Mazurowa A; Krykowski E; Pluzańska A; Dmochowska M; Robak T; Polkowska-Kulesza E; Skorek TO; Fajndt S; Boguszewska E
    Pol Tyg Lek; 1977 Apr; 32(14):521-3. PubMed ID: 854465
    [No Abstract]   [Full Text] [Related]  

  • 25. Biophysical analysis of the acute toxicity of radiotherapy in Hodgkin's lymphoma--a comparison between extended field and involved field radiotherapy based on the data of the German Hodgkin Study Group.
    Eich HT; Haverkamp U; Engert A; Kocher M; Skripnitchenko R; Brillant C; Sehlen S; Dühmke E; Diehl V; Müller RP
    Int J Radiat Oncol Biol Phys; 2005 Nov; 63(3):860-5. PubMed ID: 15925455
    [TBL] [Abstract][Full Text] [Related]  

  • 26. ABVD versus modified stanford V versus MOPPEBVCAD with optional and limited radiotherapy in intermediate- and advanced-stage Hodgkin's lymphoma: final results of a multicenter randomized trial by the Intergruppo Italiano Linfomi.
    Gobbi PG; Levis A; Chisesi T; Broglia C; Vitolo U; Stelitano C; Pavone V; Cavanna L; Santini G; Merli F; Liberati M; Baldini L; Deliliers GL; Angelucci E; Bordonaro R; Federico M;
    J Clin Oncol; 2005 Dec; 23(36):9198-207. PubMed ID: 16172458
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Radiotherapy of early stages Hodgkin's disease. 10 years experience of the Masaryk Memorial Cancer Institute.
    Petera J; Macharová H; Pohanková R; Malír A; Coupek P; Konecný M; Patera J; Pecina J; Drbal J; Koukalová H; Vásová I
    Neoplasma; 2000; 47(2):129-32. PubMed ID: 10985481
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Centralized radiation oncologic review of cross-sectional imaging of Hodgkin's disease leads to significant changes in required involved field-results of a quality assurance program of the German Hodgkin Study Group.
    Eich HT; Staar S; Gossmann A; Hansemann K; Skripnitchenko R; Kocher M; Semrau R; Engert A; Josting A; Franklin J; Krug B; Diehl V; Müller RP;
    Int J Radiat Oncol Biol Phys; 2004 Mar; 58(4):1121-7. PubMed ID: 15001253
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Feasibility of different combinations of chemotherapy (6 MOPP) plus radiotherapy in Hodgkin's disease.
    Volterrani F; Zucali R; Sigurtà D; Severini A; Santoro A
    Tumori; 1979 Dec; 65(6):729-41. PubMed ID: 543016
    [TBL] [Abstract][Full Text] [Related]  

  • 30. MOPP, ABVD, or both to treat Hodgkin's disease.
    Martino R; Nomdedeu J; Brunet S
    N Engl J Med; 1993 Apr; 328(14):1045; author reply 1045-6. PubMed ID: 7680766
    [No Abstract]   [Full Text] [Related]  

  • 31. [Comments about use of polychemotherapy MOPP associated with radiotherapy in the treatment of early stages of Hodgkin's disease. Preliminary report of 58 patients (author's transl)].
    Brun B; Alaoui Y; Kuentz M; Baillet F; Maylin C; Vernant JP; Reyes F; Rochant H; Pierquin B; Dreyfus B
    Ann Med Interne (Paris); 1980; 131(4):239-43. PubMed ID: 7425449
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of MOPP/MOPP +/- RT vs. MOPp/ABVD +/- RT in poor prognosis Hodgkin's disease. Long-term results.
    Comella P; Abate G; Fiore M; Di Finizio G; Frezza P; Scoppa G; Anania C; Coucourde F; Zarrilli D
    J Chemother; 1989 Jul; 1(4 Suppl):1254-6. PubMed ID: 16312855
    [No Abstract]   [Full Text] [Related]  

  • 33. MOPPEBVCAD chemotherapy with limited and conditioned radiotherapy in advanced Hodgkin's lymphoma: 10-year results, late toxicity, and second tumors.
    Gobbi PG; Broglia C; Levis A; La Sala A; Valentino F; Chisesi T; Sacchi S; Corbella F; Cavanna L; Iannitto E; Pavone V; Molica S; Corazza GR; Federico M
    Clin Cancer Res; 2006 Jan; 12(2):529-35. PubMed ID: 16428496
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Treatment of stages I and II Hodgkin's disease with three different therapeutic modalities.
    Koziner B; Myers J; Cirrincione C; Redman J; Cunningham I; Caravelli J; Nisce LZ; McCormick B; Straus DJ; Mertelsmann R
    Am J Med; 1986 Jun; 80(6):1067-78. PubMed ID: 3755285
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evaluation of the significance of prognostic factors in stage III Hodgkin's disease treated with MOPP and radiotherapy.
    Fuller LM; Gamble JF; Velazquez WS; Rodgers RW; Butler JJ; North LB; Martin RG; Gehan EA; Shullenberger CC
    Cancer; 1980 Mar; 45(6):1352-64. PubMed ID: 7357524
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Chemotherapy of Hodgkin disease].
    Gallmeier WM; Bruntsch U
    MMW Munch Med Wochenschr; 1982 Sep; 124(37):800-3. PubMed ID: 6813724
    [No Abstract]   [Full Text] [Related]  

  • 37. Treatment of early stages of Hodgkin's disease with novantrone, vincristine, vinblastine, prednisone, and radiotherapy.
    Hagemeister FB; Purugganan R; Fuller L; McLaughlin P; Swan F; Romaguera J; Rodriguez M; Cabanillas F
    Semin Hematol; 1994 Apr; 31(2 Suppl 3):36-43. PubMed ID: 8073308
    [No Abstract]   [Full Text] [Related]  

  • 38. [Radiotherapy of lymphogranulomatosis].
    Weidenmaier W; Röttinger EM
    MMW Munch Med Wochenschr; 1982 Sep; 124(37):795-9. PubMed ID: 6813723
    [No Abstract]   [Full Text] [Related]  

  • 39. International Symposium on Hodgkin's Disease. Session 5. Treatment. Current status of clinical trials: Stanford experience, 1962-72.
    Kaplan HS; Rosenberg SA
    Natl Cancer Inst Monogr; 1973 May; 36():363-71. PubMed ID: 4582994
    [No Abstract]   [Full Text] [Related]  

  • 40. Skin infiltration in Hodgkin's disease.
    Gordon RA; Lookingbill DP; Abt AB
    Arch Dermatol; 1980 Sep; 116(9):1038-40. PubMed ID: 7416756
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.